<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-101640</identifier>
<setSpec>0214-4840</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Psychiatric morbidity among cocaine and heroin users in the community</dc:title>
<dc:description xml:lang="en">Drug abuse is a serious public health problem. Moreover, co-occurring mental health and substance abuse disorders are common among drug users. This paper examines psychiatric disorders of young cocaine and heroin users using the World Mental Health Composite International Diagnostic Interview (WMH-CIDI). A cohort of 1266 young (18-30 years) current regular cocaine (705) and heroin (561) users were recruited outside the health services in Barcelona, Madrid and Seville, Spain. The WMH-CIDI was used to evaluate mental disorders; the Severity of Dependence Scale (SDS) measured the degree of dependence; and the Duke-UNC Functional Social Support Questionnaire (FSSQ) assessed social support, in a cross sectional study design. About 43% was diagnosed with a lifetime mental disorder. The most common diagnoses were depression (37.5%) and specific phobia (6.8%). During the last 12 months, prevalence rates were also slightly higher in heroin group (26.4%) than in cocaine cohort (21.7%). Every day cocaine consumption, having unstable living conditions and low social support were variables highly associated with psychiatric morbidity in cocaine cohort. In heroin cohort, earning money through illegal activities was associated with psychiatric morbidity, while the moderate use of alcohol acted as a protective factor for mental pathology. Morbidity was associated to having received psychiatric/psychological treatment during the last 12 months in both cohorts. This study has shown a relatively high prevalence of psychiatric morbidity in cocaine and heroin users recruited in non-clinical settings. Future studies examining differences between cocaine and heroin patterns of consumption associated with mental diseases are necessary (AU)</dc:description>
<dc:creator>Domingo-Salvany, Antonia</dc:creator>
<dc:creator>Fuente, Luis de la</dc:creator>
<dc:creator>Tortajada, Silvia</dc:creator>
<dc:creator>Molist, Gemma</dc:creator>
<dc:creator>Herrero, M Jesús</dc:creator>
<dc:creator>Brugal, M Teresa</dc:creator>
<dc:creator>Barrio, Gregorio</dc:creator>
<dc:language>en</dc:language>
<dc:description xml:lang="es">El consumo de drogas es un problema de salud pública. Entre los consumidores la presencia concomitante de trastornos mentales y abuso de sustancias son comunes. Este artículo examina los trastornos psiquiátricos que presentan jóvenes consumidores de cocaína y heroína, medidos con la World Mental Health Composite International Diagnostic Interview (WMH-CIDI).Se realizó una encuesta transversal de entrada a una cohorte de 1.266 jóvenes (18-30 años), consumidores regulares de cocaína y no heroína (705) y de 561 consumidores de heroína reclutados fuera de los servicios de salud en Barcelona, Madrid y Sevilla. Para evaluar los trastornos mentales se utilizó el WMH-CIDI, para medir el grado de dependencia la Severity of Dependence Scale (SDS), y para evaluar el apoyo social se utilizó el Cuestionario de Apoyo Social Funcional Duke-UNC. Se diagnosticó un trastorno mental al 43% de la muestra. Los diagnósticos más frecuentes fueron la depresión (37,5%) y la fobia específica (6,8%). Durante los últimos 12 meses, la prevalencia de trastorno mental en el grupo de heroína (26.4%) fue mayor que en el de cocaína (21.7%). Las variables relacionadas con la morbilidad psiquiátrica en la cohorte de cocaína fueron: el mayor número de días de consumo, las condiciones de vida inestables y el bajo apoyo social. En la cohorte de heroína, el ganar dinero a través de actividades ilegales, mientras que el consumo moderado de alcohol actuó como factor protector para la patología mental. En ambas cohortes, la morbilidad se asoció a haber recibido tratamiento psiquiátrico/psicológico durante los últimos 12 meses. Este estudio muestra una prevalencia relativamente alta de morbilidad psiquiátrica en consumidores de cocaína y heroína reclutados en entornos no clínicos. Para el futuro, son necesarios estudios que examinen las diferencias entre los patrones de consumo de cocaína y heroína y su asociación con las enfermedades mentales (AU)</dc:description>
<dc:source>Adicciones (Palma de Mallorca);24(3): 201-210, jul.-sept. 2012. tab</dc:source>
<dc:identifier>ibc-101640</dc:identifier>
<dc:title xml:lang="es">Morbilidad psiquiátrica en consumidores de cocaína y heroína reclutados en la comunidad</dc:title>
<dc:subject>^d53387^s22056</dc:subject>
<dc:subject>^d28621</dc:subject>
<dc:subject>^d28631</dc:subject>
<dc:subject>^d33535^s22080</dc:subject>
<dc:subject>^d13036^s22066</dc:subject>
<dc:subject>^d53387^s22083</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d13328</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d24772</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d8771^s22080</dc:subject>
<dc:subject>^d28596^s22045</dc:subject>
<dc:subject>^d13036^s37748</dc:subject>
<dc:subject>^d6715^s22080</dc:subject>
<dc:subject>^d33538^s22080</dc:subject>
<dc:subject>^d12049^s22045</dc:subject>
<dc:subject>^d13036^s22074</dc:subject>
<dc:subject>^d37735</dc:subject>
<dc:subject>^d53387^s22019</dc:subject>
<dc:subject>^d6447^s22066</dc:subject>
<dc:subject>^d53386</dc:subject>
<dc:subject>^d28596^s22039</dc:subject>
<dc:subject>^d6447^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201209</dc:date>
</metadata>
</record>
</ibecs-document>
